Literature DB >> 16731043

Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice.

Mohammed S Razzaque1, Beate Lanske.   

Abstract

The essential role of low levels of vitamin D during aging is well documented. However, possible effects of high levels of vitamin D on the aging process are not yet clear. Recent in vivo genetic-manipulation studies have shown increased serum level of vitamin D and altered mineral-ion homeostasis in mice that lack either fibroblast growth factor 23 (Fgf23) or klotho (Kl) genes. These mice develop identical phenotypes consistent with premature aging. Elimination or reduction of vitamin-D activity from Fgf23 and Kl mutant mice, either by dietary restriction or genetic manipulation could rescue premature aging-like features and ectopic calcifications, resulting in prolonged survival of both mutants. Such in vivo experimental studies indicated that excessive vitamin-D activity and altered mineral-ion homeostasis could accelerate the aging process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731043     DOI: 10.1016/j.molmed.2006.05.002

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  60 in total

1.  Therapeutic potential of klotho-FGF23 fusion polypeptides: WO2009095372.

Authors:  Mohammed S Razzaque
Journal:  Expert Opin Ther Pat       Date:  2010-07       Impact factor: 6.674

Review 2.  Genes against aging.

Authors:  Richard A Miller
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-28       Impact factor: 6.053

Review 3.  Is 24,25(OH)D level really high in dialysis patients with high FGF23 levels?

Authors:  Hulya Taskapan
Journal:  Int Urol Nephrol       Date:  2012-03-31       Impact factor: 2.370

Review 4.  The dualistic role of vitamin D in vascular calcifications.

Authors:  M Shawkat Razzaque
Journal:  Kidney Int       Date:  2010-10-20       Impact factor: 10.612

Review 5.  The role of Klotho in energy metabolism.

Authors:  M Shawkat Razzaque
Journal:  Nat Rev Endocrinol       Date:  2012-05-29       Impact factor: 43.330

Review 6.  Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.

Authors:  Chiara Degirolamo; Carlo Sabbà; Antonio Moschetta
Journal:  Nat Rev Drug Discov       Date:  2015-11-16       Impact factor: 84.694

Review 7.  Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters.

Authors:  Ming Chang Hu; Mingjun Shi; Orson W Moe
Journal:  Pflugers Arch       Date:  2018-12-01       Impact factor: 3.657

8.  Klotho and Na+,K+-ATPase activity: solving the calcium metabolism dilemma?

Authors:  M Shawkat Razzaque
Journal:  Nephrol Dial Transplant       Date:  2007-10-31       Impact factor: 5.992

Review 9.  Does FGF23 toxicity influence the outcome of chronic kidney disease?

Authors:  Mohammed Shawkat Razzaque
Journal:  Nephrol Dial Transplant       Date:  2008-11-07       Impact factor: 5.992

10.  IGF-1 and survival in ESRD.

Authors:  Ting Jia; Thiane Gama Axelsson; Olof Heimbürger; Peter Bárány; Bengt Lindholm; Peter Stenvinkel; Abdul Rashid Qureshi
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.